Shopping Cart 0
Cart Subtotal
USD 0

Chinese Mecobalamin Market Outlook 2017-2022

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 3000

Access to Printed Report; No Soft Copy
Print Option: N/A
Copy Option: N/A
Deliverable Format : Printed Publication/ Book by Post

Hard Copy License
USD 3100

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 5000
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase

Details

Methylcobalamin is equivalent physiologically to vitamin B12, and can be used to prevent or treat pathology arising from a lack of vitamin B12 (vitamin B12 deficiency), such as pernicious anemia. The study provides historic data of 2012-2016 along with a forecast from 2017 to 2022 based on both output/volume and revenue. The study then describes the drivers and restraints for the mecobalamin market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the mecobalamin market.

The report has been prepared based on the synthesis, analysis, and interpretation of information about the Chinese mecobalamin market collected from specialized sources. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. Company overview, financial overview, product portfolio, new project launched, recent development analysis are the parameters included in the profile. Relevantly, the report and company profiles specify the key drivers that are impacting the demand in Chinese mecobalamin market.

Key Vendors

Eisai

Shandong Keyuan

Chongqing Lummy

NCPC

Hebei Yuxing

Ningxia Kingvit

request free sample to get a complete list of companies

Key Questions Answered in this Report

What will the market size be in 2022?

What are the key factors driving the Chinese mecobalamin market?

What are the challenges to market growth?

Who are the key players in the mecobalamin market?

What are the market opportunities and threats faced by the key players?

READ MORE

Table Of Content

Scope

Part 1. Exclusive Summary

Part 2. Methodology

2.1 Research Methodology

2.2 Years Considered

Part 3. Introduction

3.1 Product Overview

3.2 Manufacturing Process

3.2.1 Raw Materials

3.2.2 Cost Analysis

Part 4. Competitive Landscape

4.1 Chinese Mecobalamin Market, by Volume 2012-2017

4.1.1 Overview

4.1.2 Chinese Mecobalamin Market, by Volume, by Company

4.1.3 Top 5 Companies by Volume Share

4.2 Chinese Mecobalamin Market, by Revenue 2012-2017

4.2.1 Overview

4.2.2 Chinese Mecobalamin Market, by Revenue, by Company

4.2.3 Top 5 Companies by Revenue Share

4.2.4 Price & Gross Margin

Part 5. Consumption Pattern

5.1 Consumption

5.2 Import & Export

Part 6. Situation & Prospect

6.1 Situation

6.2 Market Prospect

Part 7. Market Dynamics

7.1 Market Drivers

7.2 Challenges

7.3 Market Trends

Part 8. Mecobalamin Market Forecast

8.1 Chinese Mecobalamin Market Size 2017-2022

8.2 Chinese Mecobalamin Consumption 2017-2022

Part 9. Company Profiles

9.1 Eisai

9.1.1 Business Overview

9.1.2 Products Offered

9.1.3 Financials

9.2 Shandong Keyuan

9.3 Chongqing Lummy

9.4 NCPC

9.5 Hebei Yuxing

9.6 Ningxia Kingvit

9.7 Shandong Chenlong

9.8 Haiyou Freda

9.9 Beijing Lunarsun

9.10 Weihai Disu

...

Part 10. Appendix

10.1 Abbreviations

10.2 Disclaimer

Licence Rights

Single License

allows one individual to access the purchased report

Site License

allows five individuals to access the purchased report

Enterprise License

allows all employees of an organization to access the purchased report

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com